Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Vetter UN compact

Vetter joins UN Global Compact Network for sustainability

, 23 March 2023/in E-News /by panglobal

Vetter has recently become a participant of the UN Global Compact Network (UN GC). Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. The company has longterm experience in supporting biotechnology and pharmaceutical customers both large and small. […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/Vetter_UN_compact.jpg 597 500 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 14:56:272023-03-23 14:57:42Vetter joins UN Global Compact Network for sustainability
ToxTracker logo

IIVS and Toxys agree to offer ToxTracker for in vitro genetic toxicity evaluation

, 23 March 2023/in E-News /by panglobal

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay. ToxTracker is an innovative in vitro assay allowing identification of the genotoxic and potentially carcinogenic properties of novel and existing drugs, (agro)chemicals, cosmetics and other substances without the use of animal testing.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/ToxTracker-logo.png 500 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 14:53:012023-03-23 14:53:01IIVS and Toxys agree to offer ToxTracker for in vitro genetic toxicity evaluation
siemens sysmex

Siemens Healthineers and Sysmex agree to supply haemostasis instruments, reagents as OEMs

, 23 March 2023/in E-News /by panglobal

Siemens Healthineers has signed a global OEM agreement on haemostasis products with Sysmex Corporation under which each company will supply the other with their products in the diagnostic field of haemostasis on an OEM basis.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/siemens_sysmex.jpg 514 924 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 14:49:092023-03-24 11:28:31Siemens Healthineers and Sysmex agree to supply haemostasis instruments, reagents as OEMs
probiogen

ProBioGen makes three new appointments to support growth

, 23 March 2023/in E-News /by panglobal

ProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled. Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team, while Dr Michiel Stork […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/probiogen-e1680865455364.png 807 600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 14:45:582023-03-23 14:45:58ProBioGen makes three new appointments to support growth
Screenshot 2023 03 22 at 15.58.00

Vitestro raises EUR 12 million in Series A financing round to bring the world’s first autonomous blood drawing device to the European market

, 23 March 2023/in E-News /by panglobal

Vitestro, developer of an autonomous blood drawing device, announces the completion of a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/Screenshot-2023-03-22-at-15.58.00-e1680865553214.png 600 927 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 10:49:482023-03-23 10:56:46Vitestro raises EUR 12 million in Series A financing round to bring the world’s first autonomous blood drawing device to the European market
image002

Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers

, 23 March 2023/in E-News /by panglobal

Enhanced usability to support PCR applications in basic and translational research, process development, and quality control

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/image002.png 257 386 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-23 10:45:442023-03-23 10:58:29Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
image002

Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs

, 21 March 2023/in E-News /by panglobal

Services support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates PurePep® EasyClean (PEC) orthogonal purification technology for peptide purification now fully integrated into Company’s kits and services offerings

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/image002.jpg 142 252 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-21 19:00:522023-03-23 11:08:15Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs
bbbbbbbbbb

Multi-drug resistant organisms can be transmitted between healthy dogs and cats and their hospitalised owners

, 21 March 2023/in E-News /by panglobal

But only a small number of cases were found suggesting pets are not a major source of antibiotic-resistant infections in hospital patients

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/bbbbbbbbbb.jpeg 196 257 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-21 18:48:472023-03-21 18:48:47Multi-drug resistant organisms can be transmitted between healthy dogs and cats and their hospitalised owners
Clario Logo

Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials

, 21 March 2023/in E-News /by panglobal

Clario has partnered with Strados Labs to offer its customers the RESP™ Biosensor System, an advanced technological innovation for the at-home capture of lung sounds. The revolutionary device enables Clario to support the capture of additional clinical respiratory endpoints such as cough and wheeze, and it does so in a patient-friendly, streamlined way.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/Clario_Logo.jpg 130 400 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-21 18:43:022023-04-21 11:21:14Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials
Miroculus team members welcome INTEGRA visitors to their office in San Francisco

INTEGRA Biosciences acquires Miroculus to accelerate genomics

, 16 March 2023/in E-News /by panglobal

INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time savings to academic, research and diagnostics laboratories using NGS and, ultimately, accelerating discovery in […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/03/Miroculus-team-members-welcome-INTEGRA-visitors-to-their-office-in-San-Francisco.png 516 689 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-03-16 15:19:052023-03-16 15:19:05INTEGRA Biosciences acquires Miroculus to accelerate genomics
Page 41 of 228«‹3940414243›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription